CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding CytoDyn Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 9 | −2 |
| Shares | 265.0K | 406.0K | +141.0K (+53.2%) |
| Value | $37.4K | $64.6K | +$27.2K (+72.9%) |
New holders (3)
Institutions that held CytoDyn Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eagle Bay Advisors LLC | 162,113 | $25.7K | 0.01% |
| RFP Financial Group LLC | 41,450 | $6.56K | 0.00% |
| Next Capital Management LLC | 32,500 | $5.14K | 0.00% |
Sold out (5)
Institutions that held CytoDyn Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Virtue Capital Management, LLC | 45,000 | $6.35K |
| Moloney Securities Asset Management, LLC | 28,025 | $3.90K |
| S.A. Mason LLC | 19,000 | $2.64K |
| FineMark National Bank & Trust | 15,000 | $2.08K |
| Willis Investment Counsel | 13,037 | $1.81K |